Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Walther

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Ulrike Walther
Neuropediatrics|March 17, 2022
Unexpected Intermediate Nerve Conduction Velocity Findings in Charcot-Marie-Tooth Syndromes Classified as Demyelinated or Axonal in a Pediatric PopulationEloïse Baudou, Claude Cances, Corinne Magdelaine, et al.
Neuromuscular Disorders : NMD|October 19, 2025
Prevalence of pediatric neuromuscular disorders in the Southwest region of FranceMaelle Biotteau, Claude Messiaen, Elisabeth Wallach, et al.
International Journal of Molecular Sciences|April 27, 2024
The <i>Hexokinase 1</i> 5'-UTR Mutation in Charcot-Marie-Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium BufferingMaria Ceprian, Raul Juntas-Morales, Graham Campbell, et al.
Neurology|March 22, 2022
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French ExperienceAgathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Medecine Sciences : M/S|November 18, 2024
[Benefit of treatment with rituximab in autoimmune myasthenia gravis in children]Agathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
BMC Pediatrics|November 16, 2023
Confirmatory validation of the french version of the Duchenne Muscular Dystrophy module of the pediatric quality of life inventory (PedsQL<sup>TM</sup>3.0DMDfv)Elisabeth Wallach, Virginie Ehlinger, Maelle Biotteau, et al.
Clinical Genetics|July 26, 2022
HINT1 neuropathy: Expanding the genotype and phenotype spectrumVictor Morel, Emmanuelle Campana-Salort, Amandine Boyer, et al.
Neuromuscular Disorders : NMD|October 31, 2020
The importance of an integrated genotype-phenotype strategy to unravel the molecular bases of titinopathiesAurélien Perrin, Raul Juntas Morales, François Rivier, et al.
JAMA Network Open|October 8, 2025
Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1Juliette Ropars, Claude Cances, Rocio Garcia-Uzquiano, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
MMW Fortschritte Der Medizin|July 3, 2016
[Not Available]Ulrike Walther
Neuropediatrics|March 17, 2022
Unexpected Intermediate Nerve Conduction Velocity Findings in Charcot-Marie-Tooth Syndromes Classified as Demyelinated or Axonal in a Pediatric PopulationEloïse Baudou, Claude Cances, Corinne Magdelaine, et al.
Neuromuscular Disorders : NMD|October 19, 2025
Prevalence of pediatric neuromuscular disorders in the Southwest region of FranceMaelle Biotteau, Claude Messiaen, Elisabeth Wallach, et al.
International Journal of Molecular Sciences|April 27, 2024
The <i>Hexokinase 1</i> 5'-UTR Mutation in Charcot-Marie-Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium BufferingMaria Ceprian, Raul Juntas-Morales, Graham Campbell, et al.
Neurology|March 22, 2022
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French ExperienceAgathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Medecine Sciences : M/S|November 18, 2024
[Benefit of treatment with rituximab in autoimmune myasthenia gravis in children]Agathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
BMC Pediatrics|November 16, 2023
Confirmatory validation of the french version of the Duchenne Muscular Dystrophy module of the pediatric quality of life inventory (PedsQL<sup>TM</sup>3.0DMDfv)Elisabeth Wallach, Virginie Ehlinger, Maelle Biotteau, et al.
Clinical Genetics|July 26, 2022
HINT1 neuropathy: Expanding the genotype and phenotype spectrumVictor Morel, Emmanuelle Campana-Salort, Amandine Boyer, et al.
Neuromuscular Disorders : NMD|October 31, 2020
The importance of an integrated genotype-phenotype strategy to unravel the molecular bases of titinopathiesAurélien Perrin, Raul Juntas Morales, François Rivier, et al.
JAMA Network Open|October 8, 2025
Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1Juliette Ropars, Claude Cances, Rocio Garcia-Uzquiano, et al.
Pageof 3